Sign in with Google. Opens in new tab
bearish
Second Listing or Re-Packaging Assets Won't Fix Problems Revealed by Best Inc's Weak Q2 Results
374 Views18 Aug 2020 01:18
By being selective about the parcels it handled and focusing on costs, BEST Inc (BEST US) managed to lift gross margin slightly in Q2, despite...
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 4-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- Zhejiang Sanhua Intelligent Controls (2050 HK): Big Raise Supported by Cornerstones
- Curator's Cut: Building Materials Moves, Benchmarking Gold Miners & Semaglutide in India and Japan
- Korea Holdco Rerating Pullback Risk: No Retroactive Treasury Cancellation
- Nikkei 225 Index Rebalance: Rohm (6963) To Replace NTT Data Group (9613)
- [Quiddity Index] Nikkei 225 Sep25 Rebal: One ADD/DEL, Less Certain Than Before
Top Unpaywalled Insights
More »- Curator's Cut: Building Materials Moves, Benchmarking Gold Miners & Semaglutide in India and Japan
- [IO Technicals 2025/25] Bearish Momentum Strengthens
- VEON (VEON US): Launches Third Phase of Share Buyback Program After Share Pullback
- Valuations, Visas & Venture Pullback: An Equity + M&A Overview of the Education Sector in Q1 2025
- Overview #27 – The Big Beautiful Tragi-Comedy Continues
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- A Price Vs. Volume Tradeoff? Not For Firms Offering Commodity-Like Chinese Express Services04 Sep 2020
- Increased Investment from Alibaba a Blessing for YTO Express? Revisit STO Express & Think Again...03 Sep 2020
- TRACKING TRAFFIC/Chinese Express: July Growth Slows | Q2 Results Show Margin Vs Volume Tradeoff24 Aug 2020
- Second Listing or Re-Packaging Assets Won't Fix Problems Revealed by Best Inc's Weak Q2 Results18 Aug 2020
- TRACKING TRAFFIC/Chinese Express: Volumes Up | Pricing Craters | STO Pre-Announces Weak Q220 Jul 2020
- Short YTO Express: Sharp Recovery in Volume Masks Effects of Intensifying Price War14 Jun 2020
- Best Inc's Q120 Results Are Sector-Worst, No Guidance for Q2 and Beyond28 May 2020
x